PubRank

Matthieu Allez

Author PubWeight™ 58.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012 5.12
2 Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology 2013 3.45
3 Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 2012 2.95
4 Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013 2.78
5 Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008 2.50
6 CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007 2.44
7 Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2008 2.39
8 The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology 2004 2.02
9 Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2006 2.01
10 Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection. Clin Gastroenterol Hepatol 2009 1.78
11 Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 2003 1.45
12 Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol 2005 1.43
13 Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis 2012 1.39
14 Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis 2007 1.37
15 Ipilimumab-induced acute severe colitis treated by infliximab. Melanoma Res 2013 1.16
16 Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol 2010 1.15
17 Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents. Autoimmun Rev 2013 1.08
18 Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 2007 1.08
19 Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011 1.02
20 Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. J Crohns Colitis 2009 1.02
21 Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease. Gastroenterology 2011 1.00
22 Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 2013 0.99
23 Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis 2014 0.95
24 Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms. PLoS One 2012 0.93
25 Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am J Pathol 2011 0.93
26 Clinical severity scores in gastrointestinal graft-versus-host disease. Transplantation 2014 0.92
27 High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma. Dig Liver Dis 2011 0.91
28 Crohn's disease recurrence after total proctocolectomy with definitive ileostomy. Dig Liver Dis 2011 0.91
29 Efficacy of anti-TNF in Crohn's disease: how does it work? Curr Drug Targets 2010 0.89
30 Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm Bowel Dis 2012 0.88
31 Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns Colitis 2010 0.85
32 Accessory cell function of airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004 0.85
33 Portomesenteric vein thrombosis in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013 0.84
34 Anti-PD1-induced collagenous colitis in a melanoma patient. Melanoma Res 2016 0.82
35 Immunomodulatory roles of the carcinoembryonic antigen family of glycoproteins. Ann N Y Acad Sci 2006 0.81
36 A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007 0.81
37 Specific IgG response against Mycobacterium avium paratuberculosis in children and adults with Crohn's disease. PLoS One 2013 0.80
38 Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease. Clin Pharmacokinet 2015 0.80
39 Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007 0.80
40 [Meckel's diverticulum with lower digestive hemorrhage and perforation]. Gastroenterol Clin Biol 2006 0.78
41 Endoscopy as a prognostic marker in inflammatory bowel disease. Dig Dis 2013 0.77
42 Complications of biologics in inflammatory bowel disease. Curr Opin Gastroenterol 2015 0.77
43 High risk of infectious disease caused by salmonellae and mycobacteria infections in patients with Crohn disease treated with anti-interleukin-12 antibody. Clin Infect Dis 2005 0.76
44 High frequency of cholestasis in generalized pustular psoriasis: Evidence for neutrophilic involvement of the biliary tract. Hepatology 2004 0.76
45 [Exclusive ileal endometriosis]. Gastroenterol Clin Biol 2005 0.75
46 [Early anocutaneous metastases of rectal cancer after transanal resection with stapled anastomosis]. Gastroenterol Clin Biol 2004 0.75
47 Digestive Diseases. Introduction. Dig Dis 2014 0.75
48 Periostitis in a patient with inflammatory bowel disease. J Rheumatol 2012 0.75
49 [Bone and joints in inflammatory bowel disease]. Gastroenterol Clin Biol 2004 0.75
50 [Treatment strategies for inflammatory bowel disease]. Rev Prat 2005 0.75
51 Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's disease. J Laparoendosc Adv Surg Tech A 2014 0.75
52 [Crohn's disease and ulcerative colitis]. Rev Prat 2004 0.75